Skip to main content
. 2020 Jan 13;15(1):e0227413. doi: 10.1371/journal.pone.0227413

Table 1. Seroprevalence of anti-rubella antibodies according to the age and gender in Vojvodina, Serbia, 2015–2017.

Seropositive Seronegative Equivocal Total
Age group No %
(95%CI)
No %
(95%CI)
No %
(95%CI)
No OR
(95%CI)
p
Males 1y 44 48.4
(38.1–58.7)
45 49.5
(39.2–59.8)
2 2.2
(0.8–5.2)
91 250.0
(31.0–1717.3)
<0.001
2-11y 438 93.8
(91.6–95.9)
25 5.4
(3.4–7.4)
4 0.9
(0.0–1.8)
467 13.3
(1.8–99.1)
0.011
12-23y 484 95.8
(94.1–97.6)
8 1.6
(0.5–2.7)
13 2.6
(1.2–4.0)
505 3.8
(0.5–30.5)
0.210
24-49y 420 92.9
(90.5–95.3)
28 6.2
(4.0–8.4)
4 0.9
(0.0–1.8)
452 15.6
(2.1–115.3)
0.007
≥50y 235 99.2
(98.1–100.3)
1 0.4
(-0.4–1.2)
1 0.4
(-0.4–1.2)
237 1.0*
Total 1,621 92.5
(91.3–93.7)
107 6.1
(5.0–7.2)
24 1.4
(0.8–2.0)
1,752
Females 1y 30 60
(46.4–73.6)
18 36
(22.7–49.3)
2 4.0
(1.4–9.4)
50 33.3
(10.7–105.6)
<0.001
2-11y 361 91.9
(89.2–94.6)
28 7.1
(4.6–9.6)
4 1.0
(0.0–2.0)
393 4.6
(1.6–13.2)
0.005
12-23y 499 96.3
(94.67–97.9)
7 1.4
(0.4–2.4)
12 2.3
(1.0–3.6)
518 0.8
(0.2–2.8)
0.751
24-49y 416 92.9
(90.5–95.3)
30 6.7
(4.4–9.0)
2 0.4
(0.2–1.0)
448 142.9
(1.5–12.3)
0.007
≥50y 236 97.1
(94.9–99,2)
4 1.6
(0.0–3.2)
3 1.2
(0.2–2.6)
243 1.0*
Total 1,542 93.3
(92.1–94.5)
87 5.3
(4.2–6.4)
23 1.4
(0.8–2.0)
1,652
Total 1y 74 52.5
(44.3–60.7)
63 44.7
(36.5–52.9)
4 2.8
(0.1–5.5)
141 76.7
(29.9–196.7)
<0.001
2-11y 799 92.9
(91.2–94.6)
53 6.2
(4.6–7.8)
8 0.9
(0.3–1.5)
860 6.2
(2.5–15.7)
<0.001
12-23y 983 96.1
(94.9–97.3)
15 1.5
(0.8–2.2)
25 2.4
(1.5–3.3)
1,023 1.4
(0.5–3.9)
0.505
24-49y 836 92.9
(91.2–94.6)
58 6.4
(4.8–8.0)
6 0.7
(0.2–1.2)
900 6.5
(2.6–16.4)
<0.001
≥50y 471 98.1
(96.9–99.3)
5 1.0
(0.1–1.9)
4 0.8
(0.0–1.6)
480 1.0*
Total 3,163 92.9
(92.0–93.8)
194 5.7
(4.9–6.5)
47 1.4
(1.0–1.8)
3,404

*Reference value

OR–Odds Ratio; CI—Confidence Interval; p–probability

Binary Logistic Regression Analysis was used to generate odds ratios and confidence intervals.